Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Newsroom

Merck & Co., Inc. Conference Call and Audio Web Cast

TO: Pharmaceutical Analysts, Reporters and Editors
WHAT: Merck & Co., Inc. will host a conference call for pharmaceutical analysts and journalists to discuss the APPROVe study of VIOXX.
WHO: Peter S. Kim, Ph.D., president, Merck Research Laboratories
Kenneth C. Frazier, senior vice president and general counsel, Merck
Raymond P. Bain, vice president, Biostatistics and Research Decision  Sciences, Merck Research Laboratories
WHEN: Tuesday, May 30, 2006, 4:45 p.m. ET
DIAL-IN: In the United States, dial (800) 561-2813/
Passcode: 82833258

Outside of the United States, dial (617) 614-3529/
Passcode: 82833258
REPLAY:

A replay of this call will be available from 6:45 p.m. ET,
May 30 until 11:59 p.m. ET, June 13.

In the United States, dial (888) 286-8010/
Passcode: 92540523

Outside of the United States, dial (617) 801-6888/
Passcode: 92540523

WEBCAST: A live audio Web cast will be available at:
http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=190190&eventID=1326501

top

 

SITE MAP PRIVACY POLICYTERMS OF USECOPYRIGHT © 1995-2007 MERCK & CO., INC.